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immunodeficiency virus (HIV)/AIDS (UNAIDS), the
estimated number of people living with HIV/AIDS
(PLWHA) worldwide is 35.3 million as of 2012 [1].
Since the first diagnosis of HIV infection in 1985 to
2012, a total of 9410 PLWHA cases have been diag-
nosed in Korea, which is relatively low compared to the
global standard [2]. However, the number of the HIV-
infected people has increased sharply in Korea since
2000 [2].
In Korea, various studies have been conducted on
HIV/AIDS. The Korea National Institute of Health
regularly conducts laboratory-based research on HIV
patients receiving highly active antiretroviral therapy
[3]. Since the establishment of the Korean HIV/AIDS
Cohort in 2006, various papers on the incidence and
seroprevalence of HIV/AIDS in Korea have been pub-
lished [4,5]. Social science approaches deal with the
status of PLWHA under a social context in various so-
cial settings [6e8].
Since 1985, Korea has been active in developing
HIV/AIDS prevention policies and expanding the target/
risk groups for HIV testing. However, since 1998, there
has been a reduction in the number of tests carried out
due to a change in the national policy from mandatory to
voluntary HIV testing, with more emphasis on sup-
porting the cost of treatment for HIV-infected persons
and on prevention education. These are the initiatives
taken by the Korean government to prevent and treat
HIV/AIDS. In addition, it is necessary to estimate the
future incidence of HIV/AIDS in Korea to secure the
budget for the HIV/AIDS prevention policy.
In the current issue of the Osong Public Health and
Research Perspectives, one paper presents the estima-
tion and projection of HIV/AIDS incidence in Korea [9].
The authors have adopted an autoregressive integrated
moving average (ARIMA) model. The ARIMA model
has previously been used for the estimation of influenza
mortality [10], malaria incidence [11], and the incidence
of other infectious diseases [12e14].This is an Open Access article distributed under the terms of the C
creativecommons.org/licenses/by-nc/3.0) which permits unrestrict
medium, provided the original work is properly cited.
Copyright ª 2013 Korea Centers for Disease Control and PreventionHowever, the back calculation, EPI-info, and EPP
models cannot be applied to estimate the number of
HIV-infected Koreans because of limitations such as a
lack of exact statistics on AIDS cases and the unavail-
ability of specific information on commercial sex
workers, intravenous drug users, and sexually trans-
mitted infection risk groups. However, the time series
method can utilize the autocorrelation functions and
produce an estimation model based on the data of HIV
cases identified yearly or monthly [9].
This study aims to construct an estimation model
using data on HIV cases diagnosed in Korea on a yearly
basis since 1985, and forecast the number of HIV-
infected persons and changes in the epidemiological
characteristics of the infection.
In this study, one interesting trend has been observed
with respect to the gender ratio for HIV/AIDS infection
in Korea. As the number of HIV-infected persons in-
creases, the current gender ratio (HIV-infected men:
HIV-infected women, 11:1) also increases. This ratio for
newly diagnosed HIV infection is projected to be 20:1 in
2017, suggesting an increase in the current male domi-
nance in the ratio. Another interesting point is that by
2012, the majority of the HIV-infected persons will be
in their 30s (28%); however, at present, the rate of HIV
infection is increasing in persons who are in their 20s.
Thus, as the results of this study suggest, we can expect
a sharp increase in the number of HIV-infected people
who are in their 20s in the upcoming 5 years. Hence,
people in their 20s form the target group for HIV pre-
vention in Korea. In a previous study on HIV prevalence
and herpes simplex virus type 2 seroprevalence, the
Koreans in their 20s have been found to have a low rate
of infection for both these sexually transmitted diseases
[15,16]; however, it is necessary to monitor this age
group more carefully, keeping in mind the current trend
change.
Despite many studies on HIV/AIDS in Korea, we
would still like to see a viral dynamic study on HIV/
AIDS, estimating the incidence of the infection using areative Commons Attribution Non-Commercial License (http://
ed non-commercial use, distribution, and reproduction in any
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292 Editorialrobust mathematical model. This may provide another
interesting perspective on the gender ratio for HIV/
AIDS in Korea.
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